Related Experiment Video
Updated: Mar 9, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications
Sumeyya Akyol1, Jonathan Lu2, Omer Akyol3
1Vascular & Medicinal Research, Texas Heart Institute, 6770 Bertner Avenue, MC 2-255, Houston, TX 77030, USA; Department of Medical Biology, Faculty of Medicine, Turgut Ozal University, Ankara, Turkey.
Insights
Low-density lipoprotein (LDL) subfraction L5, the most electronegative, uniquely induces an atherogenic response. This review explores L5
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Atherosclerosis Research
Background:
- Cardiovascular disease (CVD) poses significant public health challenges.
- Low-density lipoprotein (LDL) is implicated in CVD development and progression.
- Emerging research identifies distinct LDL subfractions with varying effects on endothelial function.
Purpose of the Study:
- To review current knowledge on the association between LDL subfraction L5 and CVD.
- To elucidate the specific role of L5 in the pathophysiology of CVD.
- To highlight L5's contribution to atherosclerosis.
Main Methods:
- Literature review of studies investigating LDL subfractions and endothelial function.
- Analysis of research on the atherogenic properties of LDL subfraction L5.
- Synthesis of data on L5's impact on cardiovascular pathophysiology.
Main Results:
- LDL subfraction L5 is the most electronegative LDL particle.
- L5 demonstrates a unique ability to induce an atherogenic response.
- Evidence suggests L5 plays a critical role in atherosclerosis development.
Conclusions:
- LDL subfraction L5 is a key factor in CVD pathogenesis.
- Understanding L5's mechanisms is crucial for CVD prevention and treatment.
- Targeting L5 may offer novel therapeutic strategies for atherosclerosis.
Abstract:
Cardiovascular disease (CVD) is a health problem of great concern to both the public and medical authorities. Low-density lipoprotein (LDL) has been reported to play an important role in both the development and progression of CVD, but studies are underway to determine how LDL exerts its effects. In recent years, it has been found that LDL has several subfractions, each of which affects endothelial function differently; L5, the most electronegative fraction, has been shown to be unique in that it induces an atherogenic response. This review examines the current knowledge concerning the relationships between L5 and CVD and highlights the role of L5 in the pathophysiology of CVD, especially with regards to atherosclerosis.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures

